DUBLIN--(BUSINESS WIRE)--The "Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
The 'Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Wet Macular Degeneration. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.
Global API Manufacturers of Marketed Products for Wet Macular Degeneration
Coverage of API manufacturers for Wet Macular Degeneration marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.
Emerging Phase III products for Wet Macular Degeneration
This report provides a comprehensive understanding of the emerging Phase III therapies for Wet Macular Degeneration which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Key Topics Covered:
1. Report Introduction
2. Wet Macular Degeneration: Overview
- Risk Factors
- Causes
- Symptoms
- Pathophysiology
- Prognosis
- Diagnosis
- Treatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed Therapies
- Product Description
- Route of Synthesis
- Mechanism of Action
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Adverse Reactions
- Clinical Trials
- Regulatory Milestones
- Product Development Activities
- United States
- Europe
- Historical Global Sales
- Forecasted Global Sales
5. Emerging Therapies (Phase III)
- Product Description
- Research and Development
- Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bbm24b/wet_macular?w=4
